Skip to main content
PMC home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1989 May;76(2):222–226.

HBsAg-induced antigen-specific T and B lymphocyte responses in chronic hepatitis B virus carriers and immune individuals.

A Fernan 1, C J Cayzer 1, W G Cooksley 1
PMCID: PMC1541835  PMID: 2788046

Abstract

This report describes a study of in vitro proliferative and antibody responses to the hepatitis B virus surface antigen (HBsAg) of lymphocytes from chronic HBsAg carriers, subjects with naturally acquired immunity, and responders to the hepatitis B vaccine. Peripheral blood T and B lymphocytes were cultured with a wide range of concentrations of HBsAg (0.025-250 ng/ml). We were unable to detect HBsAg-specific proliferation or antibody synthesis in any of the subject groups studied, despite the use of a range of antigen concentrations, cell ratios and culture periods. The addition of recombinant interleukin 2 (rIL-2) or T cell growth factor at either initiation or day 3 of culture enhanced proliferative responses, but in an antigen-independent manner. In contrast to the proliferation observed following the addition of IL-2, the absence of responses to specific antigen suggest there may be low numbers of HBsAg-specific precursors in the peripheral blood.

Full text

PDF
222

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barnaba V., Valesini G., Levrero M., Zaccari C., Van Dyke A., Falco M., Musca A., Balsano F. Immunoregulation of the in vitro anti-HBs antibody synthesis in chronic HBsAg carriers and in recently boosted anti-hepatitis B vaccine recipients. Clin Exp Immunol. 1985 May;60(2):259–266. [PMC free article] [PubMed] [Google Scholar]
  2. Bonnard G. D., Yasaka K., Maca R. D. Continued growth of functional human T lymphocytes: production of human T-cell growth factor. Cell Immunol. 1980 May;51(2):390–401. doi: 10.1016/0008-8749(80)90270-1. [DOI] [PubMed] [Google Scholar]
  3. Cupps T. R., Gerin J. L., Purcell R. H., Goldsmith P. K., Fauci A. S. In vitro antigen-induced antibody responses to hepatitis B surface antigen in man. Kinetic and cellular requirements. J Clin Invest. 1984 Oct;74(4):1204–1213. doi: 10.1172/JCI111529. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Dusheiko G. M., Hoofnagle J. H., Cooksley W. G., James S. P., Jones E. A. Synthesis of antibodies to hepatitis B virus by cultured lymphocytes from chronic hepatitis B surface antigen carriers. J Clin Invest. 1983 May;71(5):1104–1113. doi: 10.1172/JCI110860. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Einarsson M., Kaplan L., Utter G. Purification of hepatitis B surface antigen by affinity chromatography. Vox Sang. 1978;35(4):224–233. doi: 10.1111/j.1423-0410.1978.tb02926.x. [DOI] [PubMed] [Google Scholar]
  6. Hanson R. G., Hoofnagle J. H., Minuk G. Y., Purcell R. H., Gerin J. L. Cell-mediated immunity to hepatitis B surface antigen in man. Clin Exp Immunol. 1984 Aug;57(2):257–264. [PMC free article] [PubMed] [Google Scholar]
  7. Hellström U., Sylvan S., Lundbergh P. Regulatory functions of T- and accessory-cells for hepatitis B surface antigen induced specific antibody production and proliferation of human peripheral blood lymphocytes, in vitro. J Clin Lab Immunol. 1985 Apr;16(4):173–181. [PubMed] [Google Scholar]
  8. Lane H. C., Volkman D. J., Whalen G., Fauci A. S. In vitro antigen-induced, antigen-specific antibody production in man. Specific and polyclonal components, kinetics, and cellular requirements. J Exp Med. 1981 Oct 1;154(4):1043–1057. doi: 10.1084/jem.154.4.1043. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Lanier L. L., Loken M. R. Human lymphocyte subpopulations identified by using three-color immunofluorescence and flow cytometry analysis: correlation of Leu-2, Leu-3, Leu-7, Leu-8, and Leu-11 cell surface antigen expression. J Immunol. 1984 Jan;132(1):151–156. [PubMed] [Google Scholar]
  10. Ohnuma H., Machida A., Takai E., Tsuda F., Miyamoto H., Tanaka T., Oda K., Usuda S., Nakamura T., Miyakawa Y. Translation products of pre-S(1), pre-S(2) regions and the S gene of hepatitis B virus: susceptibility of their antigenic activities to treatment with heat, urea, formalin or pepsin. Clin Exp Immunol. 1986 Dec;66(3):709–715. [PMC free article] [PubMed] [Google Scholar]
  11. Setcavage T. M., Kim Y. B. Inhibition of the immune response by Fc receptor-bound specific antibody on T lymphocytes. J Immunol. 1980 Feb;124(2):553–556. [PubMed] [Google Scholar]
  12. Sherlock S. The natural history of hepatitis B. Postgrad Med J. 1987;63 (Suppl 2):7–11. [PubMed] [Google Scholar]
  13. Sylvan S. P., Hellström U. B., Lundbergh P. R. Detection of cellular and humoral immunity to hepatitis B surface antigen (HBsAg) in asymptomatic HBsAg carriers. Clin Exp Immunol. 1985 Nov;62(2):288–295. [PMC free article] [PubMed] [Google Scholar]
  14. Uhr J. W., Möller G. Regulatory effect of antibody on the immune response. Adv Immunol. 1968;8:81–127. doi: 10.1016/s0065-2776(08)60465-4. [DOI] [PubMed] [Google Scholar]
  15. Volkman D. J., Lane H. C., Fauci A. S. Antigen-induced in vitro antibody production in humans: a model for B cell activation and immunoregulation. Proc Natl Acad Sci U S A. 1981 Apr;78(4):2528–2531. doi: 10.1073/pnas.78.4.2528. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES